CBK vs WST · P/E 11, rev $121.6M vs P/E 35, rev $1.72B
Commercial Bancgroup, Inc. Common Stock (CBK) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Commercial Bancgroup, Inc. Common Stock (CBK) is a banks - regional company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CBK revenue for 2025-12-31 was $121.6M. Net income was $37.2M. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. CBK currently screens at market cap $426.5M and trailing P/E 11.2.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CBK currently screens at market cap $426.5M and trailing P/E 11.2. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CBK and WST stock pages for the full models.
Not investment advice.